Press

Biotechnology emerges as the great ally in the face of the climate crisis

26/03/2025

Climate change · Agrifood · Food & feed · Agriculture · Bioeconomy · Circular economy

• Biotechnology has consolidated itself as a strategic tool to combat climate change, driving innovation in sectors such as agriculture, energy, and industry.
• Innovative solutions like bioenergy production, chemical recycling of plastics, and the use of microalgae are transforming key sectors.
• Thanks to biotechnology research and development, it is possible to move toward a greener and more resilient economic model.
   

AseBio

Biotechnology advances in the development of key therapies for kidney diseases

13/03/2025

• It is estimated that chronic kidney disease (CKD) affects approximately 850 million people worldwide.
• World Kidney Day highlights that implementing global early detection policies is crucial to reduce healthcare costs associated with kidney failure and improve patients’ quality of life.
• By 2040, CKD is projected to become the fifth leading cause of years of life lost, emphasizing the urgent need for global strategies to combat this disease.
   

AseBio

Women Represent 29.2% of Management Teams in Biotechnology Companies in Spain

08/03/2025

Services · Talento

• For the past seven years, women’s participation in the biotech sector has exceeded 50%, and since 2020, the representation percentage has remained at 53%.
• 60% of personnel engaged in R&D activities within biotechnology companies are women.
• At AseBio, we are celebrating the third edition of the program "A Day with a Biotech Woman," which introduces female students to the inner workings of a biotechnology company and the various career opportunities the sector offers, with a focus on encouraging entrepreneurship.
  
   

AseBio

AseBio welcomes the designation of CNCps as a Notified Body for Certifying In Vitro Diagnostic Medical Devices

20/02/2025

Healthcare · Access to innovation · Innovative drugs

• It joins the other 13 European entities authorized to assess the compliance of these products before they reach the market.
• We trust that this decision will help reduce the bottleneck caused by the high demand for certification under the new regulatory framework and the limited availability of certification capacities, which negatively impacts innovative biotechnology companies developing IVDs.
• We extend our support to the Administration, and particularly to CNCps, to facilitate companies' compliance with the requirements introduced by Regulation (EU) 2017/746 through training initiatives.
   

AseBio

BIOSPAIN 2025 returns to Barcelona with a strong commitment to internationalization: ‘Global Crossroads, Local Vibes’

18/02/2025

BioSpain

• BIOSPAIN 2025, taking place from October 7 to 9, aims to match the record-breaking figures of its last edition: more than 2,200 professionals from 34 countries worldwide, over 5,000 one-to-one meetings, and more than 81 national and international investors.
• During the presentation event, AseBio, Biocat, the Generalitat of Catalonia, and the Barcelona City Council highlighted the significance of hosting this congress in the Catalan capital once again, which will also be held in this venue in 2027 and 2029.
  
   

AseBio

Biotechnology as a Driver of Innovation in the Energy Sector

14/02/2025

Healthcare · Climate change · Bioeconomy · Circular economy

• The integration of renewable energies and the valorization of biomass are revolutionizing the biotechnology sector. Companies like Natac are leading this transformation with intelligent and sustainable biorefinery models that minimize waste and optimize energy efficiency.
• The growing need for autonomous medical devices is driving research in bio-batteries, a sustainable alternative that uses metabolic processes to generate energy. TECNALIA is working on innovative solutions that will reduce the environmental impact of the healthcare sector.
• Technology centers like Leitat are committed to biofuels, green hydrogen, and sustainable energy storage to lead the change in Europe.
  
   

AseBio

Vaccines, gene-editing-based therapies, and immunotherapies will transform the current landscape of cancer treatment

04/02/2025

Healthcare · Access to innovation · Innovative drugs · Personalized medicine · Advanced therapies

• It will also be necessary to develop therapies with fewer side effects, allowing the combination of different treatments into a single therapeutic approach to maximize efficacy.
• Biotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non-specific treatments to those tailored to the unique characteristics of each patient.
• Spain has a highly collaborative R&D ecosystem, but investment in biotechnology and knowledge transfer must be strengthened, as well as streamlining regulatory processes.

AseBio

AseBio Celebrates Its 25th Anniversary as a Key Player in the 'Invisible Revolution' That Has Shaped the Development and Growth of Biotechnology in Spain

27/11/2024

Corporate

•  The event, held at the Gran Teatro CaixaBank Príncipe Pío in Madrid, brought together more than 200 attendees, with strong institutional representation.
• With the participation of key figures in AseBio's history, the discussion focused on how the Association has established itself as a catalyst for change, a driving force behind the sector's internationalization, and a fundamental part of the evolution of its regulatory framework.
•  The celebration concluded with the screening of a special video highlighting the crucial role biotechnology plays in our daily lives and how the Association has worked over the past 25 years to make it possible: "The Invisible Revolution."
  
   

AseBio

Financing, a solid ecosystem, and regulation: key challenges for Spain to drive the Bioeconomy forward

21/11/2024

Climate change · Agrifood · Food & feed · Agriculture

• The state of the bioeconomy in Spain was analyzed during a debate sponsored by the European project ShapingBio at the fifth edition of the Green Innovation Forum.
• Organized by AseBio and the Government of Navarra through the public company Sodena, the Green Innovation Forum brought together over 200 professionals from 120 companies at the Baluarte Conference Center in Pamplona.
• On a regulatory and political level, Spain has had the Comprehensive Bioeconomy Strategy in place since 2015, but the reality is that it has not evolved or achieved a significant impact.

AseBio